top of page

Process
Technology
Partnerships
News
Contact
About
More

Use tab to navigate through the menu items.

Qubigen data representation

News

Qubigen Advances in the TBXT Challenge with Promising Early Compounds and Second-Round AI Optimization Underway

Qubigen Advances in the TBXT Challenge with Promising Early Compounds and Second-Round AI Optimization Underway

Qubigen Advances in the TBXT Challenge with Promising Early Compounds and Second-Round AI Optimization Underway

Qubigen is excited to share progress in its participation in the TBXT Challenge , an ambitious global initiative to discover inhibitors...

Jul 82 min read

Qubigen and the University of Adelaide Sign Master Agreement to Advance AI-based Drug Development

Qubigen and the University of Adelaide Sign Master Agreement to Advance AI-based Drug Development

Qubigen and the University of Adelaide Sign Master Agreement to Advance AI-based Drug Development

Qubigen is pleased to announce the signing of a Master Data Access Agreement with the University of Adelaide, formalizing a...

Jul 72 min read

Qubigen Wraps Up BIO 2025 with Over 40 Strategic Meetings and High-Impact Engagements

Qubigen Wraps Up BIO 2025 with Over 40 Strategic Meetings and High-Impact Engagements

Qubigen Wraps Up BIO 2025 with Over 40 Strategic Meetings and High-Impact Engagements

Qubigen has concluded a highly productive week in Boston focused on partnering and collaboration, highlighted by CEO Jonathan Hall’s...

Jul 41 min read

enquiries@qubigen.com

Bio21 Institute

30 Flemington Road

Parkville VIC 3052

Australia

Accelerate drug design
without exposing secrets

Connect with Us

© 2025 Qubigen. All rights reserved.

bottom of page